These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 7197719

  • 1. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK, Severson JA, Finch CE.
    J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
    [Abstract] [Full Text] [Related]

  • 2. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW, Schwartz R, Friedhoff AJ.
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [Abstract] [Full Text] [Related]

  • 3. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM, Matvienko OA, Nurk AM.
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [Abstract] [Full Text] [Related]

  • 4. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
    Globus M, Bannet J, Lerer B, Belmaker RH.
    Psychopharmacology (Berl); 1982 Oct; 78(1):81-4. PubMed ID: 6815701
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney WE.
    Science; 1978 Jul 14; 201(4351):171-3. PubMed ID: 566468
    [Abstract] [Full Text] [Related]

  • 6. Genotypic influences on striatal dopaminergic regulation in mice.
    Severson JA, Randall PK, Finch CE.
    Brain Res; 1981 Apr 06; 210(1-2):201-15. PubMed ID: 6261873
    [Abstract] [Full Text] [Related]

  • 7. Effect of duration of haloperidol treatment on DA receptor supersensitization in aging C57BL/6J mice.
    Randall PK, Severson JA, Hurd SM, McClure WO.
    Brain Res; 1985 Apr 29; 333(1):85-95. PubMed ID: 4039618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
    Schröder U, Schröder H, Augustin W, Sabel BA.
    J Pharmacol Exp Ther; 1994 Dec 29; 271(3):1193-6. PubMed ID: 7996425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduced dopaminergic binding during aging in the rodent striatum.
    Severson JA, Finch CE.
    Brain Res; 1980 Jun 16; 192(1):147-62. PubMed ID: 6155174
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M, Uzunov P, Costa E.
    J Pharmacol Exp Ther; 1977 Sep 16; 202(3):558-64. PubMed ID: 19618
    [No Abstract] [Full Text] [Related]

  • 16. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH, Diamond BI.
    Biol Psychiatry; 1981 Apr 16; 16(4):365-71. PubMed ID: 7194695
    [Abstract] [Full Text] [Related]

  • 17. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Apr 16; 84(4):512-9. PubMed ID: 6441952
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH, Wilcox RE, Vaughn DM, Smith RV.
    Psychopharmacology (Berl); 1982 Apr 16; 77(2):146-9. PubMed ID: 6812131
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.